| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3355808 | Immunology Letters | 2010 | 7 Pages |
Abstract
Therefore, the proposed inhibition of Kv1.3 channels as a novel therapeutic approach for the treatment of type 1 diabetes mellitus may have a major effect on overall lymphocyte function in this disease.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Gergely Toldi, Barna Vásárhelyi, Ambrus Kaposi, GergÅ Mészáros, Pál Pánczél, Nóra Hosszufalusi, Tivadar Tulassay, András Treszl,